Raffles Medical Group
Raffles Medical Group is a private healthcare provider in Asia, operating medical facilities in thirteen cities in Singapore, China, Japan, Vietnam and Cambodia.
See below for the Latest Raffles Medical Group News, Analysis, Profit Results, Share Price Information, and Commentary.
Raffles Medical CEO tightens grip with $0.99 share sweep
Raffles Medical CEO tightens grip with $0.99 share sweep
Dr Loo Choon Yong bought 159,100 shares, raising his total interest to 56.29%.
Raffles Medical PATMI up 13.4% on stronger hospital services, insurance arm
Hospital services accounted for $41.1m of the profit.
Raffles Medical Group names new Chief Technology Officer
Foo holds a degree in Computer Science and Information Systems from NUS.
Raffles Medical Group’s profit drops 31% in FY2024
Revenue increased 6.3% YoY to $751.6m.
Raffles Medical Group’s profit drops 48.8% YoY to $30.6m in H1
Revenue slipped 1.4% to $365.7m in the same period.
Raffles Medical chairman acquires 800,000 shares, raising stake
His latest purchase increased his stake to 54%.
Raffles Medical chairman increases stake with 900,000 share purchase
Loo Choon Yong acquired the new shares for $1.02 apiece.
Raffles Medical Group’s PATMI drops 37.1% YoY to $90.2m in FY23
The company attributed the decline to the discontinuance of its COVID-related activities.
Raffles Medical Group’s profit falls 67.4% YoY top $12.4m in 3Q23
Year-to-date, the company’s profit has declined 25.6% YoY.
Raffles Medical Group’s PATMI rises slightly by 0.5% YoY to $59.9m in 1H23
Its revenue, however, fell by 9.5% YoY.
Raffles Medical’s profit after tax soars 71.7% YoY to $143.7m in FY22
The company attributed the increase to the return of foreign patients.
Raffles Medical Group to get higher margins amidst China reopening
Elective surgery revival will benefit the hospital group.
After mitigating cost pressures, Raffles Medical records 62.1% net profit growth
One of the biggest medical groups posted a net profit of $38.3m.
Raffles Medical Group to get positive contribution from China operations: analyst
Its target price was at $1.60.
Raffles Medical H1 profit surges 54.4%
Patient numbers had increased on the back of recovering medical tourism.
Raffles Medical Group to see a 10% decline in H122 net profit: forecast
This is on the back of expected lower revenue from the hospital's COVID-19 services.
Read Here
Advertise
Sign Up
Commentary
Faster hiring alone will not fix construction’s productivity problem
Beyond policy: How Singapore's service sector can win at the frontline
Solving the production problem behind Singapore’s ‘pilot purgatory’
Transformation without disruption: Your Existing ERP is an accelerant to business innovation
From Singapore to Southeast Asia: Thriving in innovation by knowing when to pause
Section 13O, MAS, and the digital footprint of Singapore Family Offices
Could Singapore lead the world's next management revolution?
RIE2030’s real test: Turning innovation into impact
What Singapore logistics operators often overlook when electrifying fleets
Singapore's mid-market leadership problem nobody is talking about